Loading...
Targeted therapies in rheumatoid arthritis: Focus on rituximab
B-cell depletion is a new strategy for treating patients with rheumatoid arthritis (RA). In the past years, several studies have proven the efficacy of anti-CD20 mediated B-cell depletion with rituximab (Mabthera(®)) in RA patients who failed TNF-blocking therapy. The important role of B-cells in th...
Na minha lista:
Main Authors: | , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Dove Medical Press
2007
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2721296/ https://ncbi.nlm.nih.gov/pubmed/19707303 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|